We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First Therapeutic Approved for Rare Skin Cancer

News   Mar 28, 2017 | Original story from Fred Hutchinson Cancer Research Center

 
First Therapeutic Approved for Rare Skin Cancer

Dr. Paul Nghiem. Credit: Fred Hutchinson Cancer Research Center

 
 
Advertisement
 

RELATED ARTICLES

Drug That Targets Challenging Cancer Mutation Could Treat Several Tumor Types

News

A new clinical trial shows a novel drug designed to counter the effects of an important cancer mutation could be effective against a range of tumor types including lung and gynecological cancers.

READ MORE

Key Pathway Offers New Clues for Targeting Drug-Resistant Colon Cancers

News

Scientists at ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a link between two key signaling pathways that are vital to the development and growth of colon cancer.

READ MORE

New Model Could Improve Design of Vaccines and Immunotherapies

News

Researchers at the Pritzker School of Molecular Engineering (PME) at the University of Chicago have discovered a general property for understanding how immune cells sense and respond to microbial signals.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE